Study finds ‘no clear evidence’ of calcium supplements affecting cardiovascular death

By Stephen DANIELLS

- Last updated on GMT

Study finds ‘no clear evidence’ of calcium supplements affecting cardiovascular death
There is ‘no clear evidence’ that calcium supplements may increase the risk of cardiovascular problems, says a new analysis from an international team of researchers.

Analysis of data from the third National Health and Nutrition Examination Survey (NHANES III) indicated that calcium is involved in cardiovascular health, with an increased risk of cardiovascular death linked to low​ calcium levels.

“Overall, we found an increased risk of cardiovascular death when serum calcium levels were less than 1.16 mmol/L compared to 1.16–1.31 mmol/L, but for women, there was an increased [ischemic heart disease] mortality among women with high serum calcium levels (greater than 1.31 mmol/L),” ​wrote the researchers.

“No associations were found between cardiovascular death and dietary or supplement calcium intake.

“However, there was a protective effect for total calcium intake of 1300–2000 mg/day and death from IHD among men.”

Researchers from King's College London (UK), Uppsala University (Sweden), Helmholtz Zentrum München (Germany), the University of Zurich (Switzerland), and Universidad Peruana de Ciencias Aplicadas (Peru), report their findings in PLoS One​.

Controversy

Several reports in the literature have questioned the safety of calcium supplements taken to reduce the risk of osteoporosis in terms of a possible increase in the risk of cardiovascular problems​. Most recently, a report in JAMA Internal Medicine​ concluded that high intakes of calcium from supplements may increase the risk of cardiovascular disease for men, but not women.

That study, a reanalysis of data from the National Institutes of Health-AARP Diet and Health Study, was described as “inappropriate”​ by a leading dietary supplements trade association, because it was initially designed to examine the potential associations between diet and cancer.

Taylor Wallace, PhD, senior director, scientific and regulatory affairs for the Council for Responsible Nutrition (CRN), told us in February: “They are mining data from this cohort to address a question that it was not designed to answer.”

On the other hand, a recent report from the Institute of Medicine concluded that “evidence from clinical trials currently does not support an effect of calcium intake on risk of cardiovascular disease”.

In addition, Harvard Medical School researchers reported in November​ no link between calcium supplements and an increased risk of artery calcification, according to analysis of data from the Framingham Offspring Study published in the American Journal of Clinical Nutrition​.

New data

For the new study, data from 20,024 people were analyzed to estimate the risk of cardiovascular death. During the course of the study, 10% of the people died of heart disease.

People in the bottom 5% for calcium levels had a 50% increased risk of dying from heart disease.

An increase in risk for women with the very highest levels of calcium was observed for death from ischemic heart disease. On the other hand, low calcium levels were associated with an increased risk of IHD mortality

“The current study suggests that calcium is involved in cardiovascular health,”​ wrote the researchers.

“However there was no strong evidence for an association between calcium supplement usage and cardiovascular death indicating that calcium supplement usage may be a marker of healthy life style despite adjustments for comorbidities, smoking, alcohol consumption, and levels of physical activity.”

Source: PLoS One
Volume 8, Number 4, e61037, doi: 10.1371/journal.pone.0061037
“Calcium Intake and Serum Concentration in Relation to Risk of Cardiovascular Death in NHANES III”
Authors: M. Van Hemelrijck, K. Michaelsson, J. Linseisen, S. Rohrmann 

Related news

Show more

Related products

show more

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Sports Nutrition Formulations Re-imagined

Sports Nutrition Formulations Re-imagined

Content provided by Gencor | 30-Sep-2024 | White Paper

Gencor offers scientifically proven sports nutrition solutions intentionally designed for optimal performance and recovery for any level of athletic activity,...

Tackling Metabolic Health with HIMABERB® Berberine

Tackling Metabolic Health with HIMABERB® Berberine

Content provided by Pharma Base S.A. | 18-Sep-2024 | White Paper

Metabolic health is a prevalent and rapidly growing global challenge. In recent years, there has been mounting clinical evidence to support the use of...

UthPeak® NMNH Million Dollars Subsidy Program

UthPeak® NMNH Million Dollars Subsidy Program

Content provided by Effepharm Ltd | 29-Jul-2024 | Product Brochure

Introducing the UthPeak® Million Dollar Campaign! Unlock the full marketing potential of the groundbreaking reduced NMN, NMNH.

Related suppliers

Follow us

Products

View more

Webinars